Zopiclone and Tarceva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zopiclone (eszopiclone) and Tarceva (erlotinib hydrochloride). Common drug interactions include diarrhoea among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Zopiclone and Tarceva. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Zopiclone?

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 54,330 Zopiclone users. Check the latest studies of Zopiclone.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

On Jul, 19, 2026

12 people who take Zopiclone and Tarceva together, and have interactions are studied.

Zopiclone and Tarceva drug interactions.

What are the common drug interactions of Zopiclone and Tarceva, by gender? *:

female:

Diarrhoea
Neutropenia (an abnormally low number of neutrophils)
Abdominal discomfort
Anaphylactic reaction (serious allergic reaction)
Back pain
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Cellulitis (infection under the skin)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Cough
Disease progression

male:

Death
Lung disorder (lung disease)
Dyspepsia (indigestion)
Fungal infection
Gait disturbance
General physical health deterioration (weak health status)
Hepatic enzyme increased
Hypokinesia (decreased bodily movement)
Hypoxia (low oxygen in tissues)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)

What are the common drug interactions of Zopiclone and Tarceva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaphylactic reaction (serious allergic reaction)
Back pain
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Cellulitis (infection under the skin)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Diarrhoea
Disease progression
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Electrocardiogram st segment elevation

50-59:

n/a

60+:

Death
Lung disorder (lung disease)
Fungal infection
General physical health deterioration (weak health status)
Hypokinesia (decreased bodily movement)
Hypoxia (low oxygen in tissues)
Malignant neoplasm progression (cancer tumour came back)
Pain
Pneumonia pneumococcal (pneumococcal pneumonia is a common but serious infection and inflammation of the lungs)
Prostatic specific antigen increased

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 33.33%
Metastases To Bone (cancer spreads to bone): 3 people, 25.00%
Pain: 2 people, 16.67%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 16.67%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 16.67%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Prostate Cancer Metastatic: 1 person, 8.33%
Prostate Cancer: 1 person, 8.33%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zopiclone and Tarceva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously